Few small molecule negative allosteric modulators (NAMs) of dopamine D2 receptor are known (SB269,652 [17]; homocysteine and analogs [18]) and their usefulness in schizophrenia needs to be further evaluated. Here, DRD2 is linked to schizophrenia.